Bernard A. Ruether

640 total citations
21 papers, 519 citations indexed

About

Bernard A. Ruether is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Bernard A. Ruether has authored 21 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 7 papers in Immunology and 6 papers in Oncology. Recurrent topics in Bernard A. Ruether's work include Multiple Myeloma Research and Treatments (10 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Bernard A. Ruether is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Bernard A. Ruether collaborates with scholars based in Canada and India. Bernard A. Ruether's co-authors include L M Pilarski, Michael J. Mant, Linda M. Pilarski, M. J. Mant, Andrew R. Belch, E. Andrews, Horacio M. Serra, Gitte S. Jensen, Jeffrey A. Ledbetter and Ashley Jones and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Annals of Oncology.

In The Last Decade

Bernard A. Ruether

21 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard A. Ruether Canada 14 364 172 135 131 130 21 519
Mette Kjær Killie Norway 14 599 1.6× 170 1.0× 52 0.4× 109 0.8× 120 0.9× 28 787
R. Hintermeíer-Knabe Germany 6 314 0.9× 319 1.9× 64 0.5× 51 0.4× 54 0.4× 8 488
AP Sheridan United States 5 204 0.6× 129 0.8× 47 0.3× 46 0.4× 59 0.5× 8 323
Pamela Ely United States 10 100 0.3× 139 0.8× 49 0.4× 70 0.5× 85 0.7× 22 377
M Saitta Italy 11 163 0.4× 93 0.5× 38 0.3× 51 0.4× 65 0.5× 20 345
Henriëtte M. Goselink Netherlands 10 272 0.7× 207 1.2× 111 0.8× 21 0.2× 80 0.6× 18 464
K Hirashima Japan 12 295 0.8× 78 0.5× 134 1.0× 19 0.1× 99 0.8× 44 465
G. W. Löhr Germany 10 90 0.2× 119 0.7× 77 0.6× 35 0.3× 46 0.4× 18 386
Colin Story Australia 11 162 0.4× 125 0.7× 68 0.5× 21 0.2× 74 0.6× 21 371
G. J. M. Lafeber Netherlands 15 49 0.1× 199 1.2× 45 0.3× 100 0.8× 53 0.4× 21 416

Countries citing papers authored by Bernard A. Ruether

Since Specialization
Citations

This map shows the geographic impact of Bernard A. Ruether's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard A. Ruether with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard A. Ruether more than expected).

Fields of papers citing papers by Bernard A. Ruether

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard A. Ruether. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard A. Ruether. The network helps show where Bernard A. Ruether may publish in the future.

Co-authorship network of co-authors of Bernard A. Ruether

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard A. Ruether. A scholar is included among the top collaborators of Bernard A. Ruether based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard A. Ruether. Bernard A. Ruether is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Russell, JA, A Chaudhry, Karen Booth, et al.. (2000). Early outcomes after allogeneic stem cell transplantation for leukemia and myelodysplasia without protective isolation: A 10-year experience. Biology of Blood and Marrow Transplantation. 6(2). 109–114. 50 indexed citations
3.
Stewart, Douglas A., Dan Guo, Bernard A. Ruether, et al.. (1997). Single-agent high-dose melphalan salvage therapy for Hodgkin's disease: Cost, safety, and long-term efficacy. Annals of Oncology. 8(12). 1277–1279. 11 indexed citations
4.
Jensen, Gitte S., Andrew R. Belch, Michael J. Mant, et al.. (1993). Expression of multiple β1 integrins on circulating monoclonal B cells in patients with multiple myeloma. American Journal of Hematology. 43(1). 29–36. 55 indexed citations
5.
Russell, Jeffrey A., MC Poon, Ashley Jones, Richard C. Woodman, & Bernard A. Ruether. (1992). Allogeneic bone-marrow transplantation without protective isolation in adults with malignant disease. The Lancet. 339(8784). 38–40. 31 indexed citations
6.
Jensen, Gitte S., et al.. (1992). Expression of Multiple Adhesion Molecules on Circulating Monoclonal B Cells in Myeloma. Current topics in microbiology and immunology. 182. 187–193. 7 indexed citations
8.
Russell, J A, Bernard A. Ruether, & Ashley Jones. (1991). The use of folinic acid with methotrexate and trimethoprim sulfamethoxazole after allogeneic bone marrow transplantation. 1. 72. 1 indexed citations
9.
Poon, Man‐Chiu, et al.. (1991). Red Blood Cell Alloimmunization Complicating Plasma Transfusion. American Journal of Clinical Pathology. 96(2). 201–202. 12 indexed citations
10.
Russell, Jeffrey A., Ashley Jones, B Houwen, Man‐Chiu Poon, & Bernard A. Ruether. (1989). Double autologous bone marrow transplantation for acute myelogenous leukemia in a patient treated for Hodgkin's disease. Medical and Pediatric Oncology. 17(5-6). 524–527. 1 indexed citations
12.
Pilarski, L M, E. Andrews, Horacio M. Serra, Bernard A. Ruether, & M. J. Mant. (1989). Comparative Analysis of Immunodeficiency in Patients with Monoclonal Gammopathy of Undetermined Significance and Patients with Untreated Multiple Myeloma. Scandinavian Journal of Immunology. 29(2). 217–228. 19 indexed citations
13.
Poon, Man‐Chiu, J A Russell, Gary Sinclair, et al.. (1989). Hemopoietic origin of factor XIII A subunits in platelets, monocytes, and plasma. Evidence from bone marrow transplantation studies.. Journal of Clinical Investigation. 84(3). 787–792. 46 indexed citations
14.
Jones, Ashley, Joseph D. Ruether, & Bernard A. Ruether. (1988). Staging laparotomy in Hodgkin's disease: A community hospital experience. Journal of Surgical Oncology. 38(4). 217–220. 6 indexed citations
15.
Serra, Horacio M., Michael J. Mant, Bernard A. Ruether, Jeffrey A. Ledbetter, & L M Pilarski. (1988). Selective loss of CD4+ CD45R+ T cells in peripheral blood of multiple myeloma patients. Journal of Clinical Immunology. 8(4). 259–265. 43 indexed citations
16.
Pilarski, Linda M., Michael J. Mant, & Bernard A. Ruether. (1987). Analysis of immunodeficiency in multiple myeloma: Observations and hypothesis. Journal of Clinical Laboratory Analysis. 1(2). 214–228. 15 indexed citations
17.
Pilarski, Linda M., E. Andrews, Michael J. Mant, & Bernard A. Ruether. (1986). Humoral immune deficiency in multiple myeloma patients due to compromised B-cell function. Journal of Clinical Immunology. 6(6). 491–501. 43 indexed citations
20.
Pilarski, L M, M. J. Mant, Bernard A. Ruether, & Andrew R. Belch. (1984). Severe deficiency of B lymphocytes in peripheral blood from multiple myeloma patients.. Journal of Clinical Investigation. 74(4). 1301–1306. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026